在线观看人与动牲交视频_夜夜高潮次次欢爽AV女_奇米在线视频观看_欧美精品七区_色悠久久综合网_少妇潮喷无码白浆水视频

上海近岸科技novoprotein   
上海近岸科技有限公司（原欣百諾生物）成立于2004年，是國(guó)內(nèi)首家專門從事重組蛋白質(zhì)制備工藝開(kāi)發(fā)及生產(chǎn)的高科技企業(yè)。novoprotein 隸屬于上海近岸科技有限公司，提供重組蛋白制備相關(guān)的全套技術(shù)服務(wù)，包括：基因合成、表達(dá)載體構(gòu)建、發(fā)酵、純化、質(zhì)量檢測(cè)、活性檢測(cè)及后期加工處理；我們也生產(chǎn)高品質(zhì)細(xì)胞因子、生物活性酶等重組蛋白質(zhì)相關(guān)的試劑產(chǎn)品。

novoprotein 目前成熟的表達(dá)體系包括大腸桿菌、酵母、昆蟲(chóng)細(xì)胞和哺乳動(dòng)物細(xì)胞表達(dá)系統(tǒng)，每種表達(dá)系統(tǒng)都具有克級(jí)以上的制備能力。novoprotein 建立了嚴(yán)格的產(chǎn)品質(zhì)控體系及一整套完善的客戶服務(wù)流程、保密制度以確保為客戶提供優(yōu)質(zhì)的產(chǎn)品及一流的服務(wù)。

基于公司出色的重組蛋白質(zhì)制備平臺(tái)，novoprotein 研發(fā)生產(chǎn)的細(xì)胞因子、酶試劑產(chǎn)品憑借其優(yōu)良的品質(zhì)、高性價(jià)比贏得了海外細(xì)胞因子及生物試劑銷售商的認(rèn)可，目前我們已與海外十幾家細(xì)胞因子與生物試劑銷售企業(yè)建立了合作關(guān)系。

八年來(lái)，我們已完成了千余種重組蛋白質(zhì)的制備，并開(kāi)發(fā)、制備了40多種分子生物學(xué)酶和600余種細(xì)胞因子。因?yàn)閷Ｗ⑺愿鼘I(yè)，我們正在
努力打造重組蛋白質(zhì)制備領(lǐng)域內(nèi)的旗艦企業(yè)。

SinoBio Biotech (Shanghai) was established in 2004 as an industrial biotechnology initiative from Fudan University. SinoBio understands that protein purification projects are labor intensive, time consuming and riddled with unpredictable outcomes. SinoBio addresses this need for efficient purification services by assembling a team of seasoned biochemists and implementing a streamlined workflow using proprietary chromatographic technologies. The result is SinoBio's highly efficient and scalable pipeline process of recombinant protein purification and production.

Track Record
In four years of commercial operation with 20 scientists, SinoBio has purified nearly 500 recombinant proteins, mg to gram scale, becoming the foremost provider of recombinant protein services to Eastern Asia. SinoBio is also a preferred bulk supplier of 50 enzymes and cytokines to US and European biotechnology reagent vendors. Five drug-related proteins are currently in preclinical trials and one protein is the basis of an IND filing. Scientists in SinoBio Biotech have taken part in 9 major protein drug process development projects, representing one third of biologics in the China protein drug market.